News

Stremvelis is a stem cell gene therapy created from the patient’s own cells. It was designated as an orphan medicinal product in August 2005. It was originally developed

Based upon the documented relationship of P450 and certain potential drug-drug interactions, this positive data is central to the planned Phase 2 clinical trial where Kevetrin will be

The acquisition will further establish Humanwell and PuraCap in the US generics market and expand their existing commercial and manufacturing capabilities. The acquisition of Epic will provide a

VI Partners and High-Tech Gründerfonds also participated in the round which will help progress Amal’s cancer vaccines. Amal Therapeutics is a Swiss biotech company developing and progressing therapeutic

A team from Purdue University and the National Institutes of Health used cryo-electron microscropy to create the picture of a mature Zika virus particle. The process included freezing

The company said its decision was not based on any emerging safety concerns from the phase 3 clinical trials with fulranumab. Janssen Pharmaceuticals is terminating its licensing deal

"FDA’s approval of Defitelio underscores the importance of Defitelio to children and adults as the first and only proven treatment for this rare and often deadly complication of

The new pre-clinical studies demonstrated both a statistically significant reduction of inflammation (65% decrease in F4/80, and 80% decrease in CD64), as well as a statically significant effect

The local ethics committee, responsible for oversight and allowance of the trial, granted this approval, so the trial can now move forward. Cellceutix is now awaiting the country’s